Inclusion Criteria:  Age ≥18 years Diagnosis of non-infectious intermediate, posterior, or panuveitis in at least one eye Active uveitic disease at Screening/Baseline defined by the presence of at least 1 of the following parameters: 1) Active, inflammatory, chorioretinal and/or inflammatory retinal vascular lesion 2) ≥ 1+ vitreous haze (NEI/SUN criteria)  Exclusion Criteria:  Presence of isolated anterior uveitis Evidence of macular edema due to diabetes, retinal vein occlusion or any other ocular conditions Confirmed or suspected active ocular disease or infections Intraocular surgery in the past 6 months History of glaucoma Intraocular pressure (IOP) of >21 mmHg at Screening/Baseline or confirmed normal-tension glaucoma Intravitreal or periocular injection within 6 months prior to screening. Unable to tolerate systemic corticosteroids Prior topical corticosteroid within 1 month of screening Prior non-steroidal anti-inflammatory, systemic steroids, or immunomodulatory therapy (e.g. methotrexate) within 1 month of screening For women: pregnant or breast feeding, or planning to become pregnant while enrolled in the study